Skip to main content
. 2023 Oct 20;72(42):1140–1146. doi: 10.15585/mmwr.mm7242e1

TABLE 1. Recommended COVID-19 vaccination schedule for persons aged 6 months–4 years who are not moderately or severely immunocompromised,* by COVID-19 vaccination history — United States, September 2023.

Previous COVID-19 vaccination history (before updated mRNA vaccine) Updated mRNA vaccine No. of updated mRNA vaccine doses indicated Interval between doses
Unvaccinated
Moderna
2
Dose 1 and dose 2: 4–8 wks
Pfizer-BioNTech
3
Dose 1 and dose 2: 3–8 wks
Dose 2 and dose 3: ≥8 wks
Received Moderna vaccine
1 dose any Moderna
Moderna
1
4–8 wks after last dose
≥2 doses any Moderna
Moderna
1
≥8 wks after last dose
Received Pfizer-BioNTech vaccine
1 dose any Pfizer-BioNTech
Pfizer-BioNTech
2
Dose 1: 3–8 wks after last dose
Dose 1 and dose 2: ≥8 wks
2 doses any Pfizer-BioNTech
Pfizer-BioNTech
1
≥8 wks after last dose
≥3 doses any Pfizer-BioNTech Pfizer-BioNTech 1 ≥8 wks after last dose

* Additional clinical considerations, including detailed schedules and tables by age and vaccination history for those who are and are not moderately or severely immunocompromised, are available. https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html

https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html#not-immunocompromised